Middle East & Africa Crispr-based Gene Editing Market Size & Outlook

The crispr-based gene editing market in Middle East & Africa is expected to reach a projected revenue of US$ 205.6 million by 2033. A compound annual growth rate of 11.4% is expected of Middle East & Africa crispr-based gene editing market from 2025 to 2033.
Revenue, 2024 (US$M)
$79.3
Forecast, 2033 (US$M)
$205.6
CAGR, 2025 - 2033
11.4%
Report Coverage
Middle East & Africa

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Middle East & Africa crispr-based gene editing market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

MEA crispr-based gene editing market highlights

  • The MEA crispr-based gene editing market generated a revenue of USD 79.3 million in 2024.
  • The market is expected to grow at a CAGR of 11.4% from 2025 to 2033.
  • In terms of segment, product was the largest revenue generating type in 2024.
  • Service is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, Saudi Arabia is expected to register the highest CAGR from 2025 to 2033.


MEA data book summary

Market revenue in 2024USD 79.3 million
Market revenue in 2033USD 205.6 million
Growth rate11.4% (CAGR from 2025 to 2033)
Largest segmentProduct
Fastest growing segmentService
Historical data covered2021 - 2023
Base year for estimation2024
Forecast period covered2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationProduct, Service
Key market players worldwideRevvity Inc, Danaher Corp, Genscript Biotech Corp Class H, Merck KGaA, Thermo Fisher Scientific, Inc., Bio-Techne Corp, Origene Technologies, Bio-Rad Laboratories Inc Class A, New England Biolabs


Other key industry trends

  • In terms of revenue, MEA region accounted for 2.0% of the global crispr-based gene editing market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 3,558.5 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

CRISPR-based Gene Editing Market Companies

Name Profile # Employees HQ Website
Thermo Fisher Scientific, Inc. View profile - - -
Bio-Rad Laboratories Inc Class A View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Origene Technologies View profile 501-1000 Rockville, Maryland, United States, North America http://www.origene.com
New England Biolabs View profile 501-1000 Ipswich, Massachusetts, United States, North America http://neb.com
Genscript Biotech Corp Class H View profile 6937 No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, China, People's Republic of, 211100 https://www.genscript.com
Bio-Techne Corp View profile 3050 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 https://www.bio-techne.com
Revvity Inc View profile 11500 940 Winter Street, Waltham, MA, United States, 02451 https://www.revvity.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com

Middle East & Africa crispr-based gene editing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to crispr-based gene editing market will help companies and investors design strategic landscapes.


Product was the largest segment with a revenue share of 80.33% in 2024. Horizon Databook has segmented the Middle East & Africa crispr-based gene editing market based on product, service covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Middle East & Africa crispr-based gene editing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa crispr-based gene editing market databook

  • Our clientele includes a mix of crispr-based gene editing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa crispr-based gene editing market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa crispr-based gene editing market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

MEA crispr-based gene editing market size, by country, 2021-2033 (US$M)

Middle East & Africa CRISPR-based Gene Editing Market Outlook Share, 2024 & 2033 (US$M)

MEA crispr-based gene editing market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online